A treat-to-target approach to managing rheumatoid arthritis can work even in pregnant women
ACR Releases Guidelines for Gout Management
The American College of Rheumatology’s two-part guidelines stress the need for treating to target, more aggressive management, and therapy
How Microbes, Mycobacteria, and Metastases May Alter the Way We Look at Rheumatic Diseases
Studying the relationships between microbes and their hosts, the role for Bacille Calmette Guerin (BCG) as a vaccine for Type I diabetes, and emotional stress and bone metastases
Nomenclature, Semantics, Jargon, Lingo, Eponyms, Etymology, and Terminology in Rheumatology
Why rheumatologists must coin simple, comprehensible terms for what we read, speak and write to our patients
Studies Show Promise for Scleroderma Therapy and Prediction of Progressing Disease
Research shows that a serum from goats might be helpful in combating diffuse cutaneous systemic sclerosis (SSc)
EULAR: Identify Arthritis Early, Treat it Effectively
Recent studies are uncovering genetic and environmental factors at play in the earliest stages of rheumatoid arthritis and medications that are effective in treating juvenile idiopathic arthritis
Morris Reichlin Contributes Five Decades of Immunologic Advances in Rheumatology
Career marked by the quest to define the antigenic targets of autoimmunity in people with systemic lupus erythematosus (SLE), inflammatory myopathies, polymyositis, and dermatomyositis
Maintenance of Remission in ANCA-Associated Vasculitis
Relapses are common, but difficult to predict and prevent.
EULAR 2012: MicroRNAs’ Role in Rheumatic Diseases Coming into Sharper Focus
MicroRNAs are poised to play a big role in the future understanding and treatment of rheumatoid arthritis.
Coding Corner Question: September’s Coding Challenge
How the case is coded.
- « Previous Page
- 1
- …
- 287
- 288
- 289
- 290
- 291
- …
- 330
- Next Page »